AZN tahvilleri
Aşağıda ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 şirket tahvillerinin listesi bulunmaktadır. Yatırımcılar genellikle piyasa dalgalanması zamanlarında artan istikrarları için bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol | Vade sonu getirisi % | Kupon % | Vade Tarihi | Ödenmemiş tutar | Nominal değer | Asgari brm tutarı | İhraççı |
|---|---|---|---|---|---|---|---|
 US46353AM0ASTRAZENECA PLC 15/45 | 4,83% | 4,38% | 2045-11-16 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| US46353AU2ASTRAZENECA 18/48 | 4,79% | 4,38% | 2048-08-17 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| ZEGBASTRAZENECA PLC 12/42 | 4,72% | 4,00% | 2042-09-18 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| AZN.GEAstraZeneca 6.45% 15-SEP-2037 | 4,61% | 6,45% | 2037-09-15 | 2,75 B USD | 1.000,00 USD | 1.000,00 USD | AstraZeneca PLC |
| US46353AZ1ASTRAZENECA 21/51 | 4,60% | 3,00% | 2051-05-28 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| US46353AX6ASTRAZENECA 20/50 | 4,49% | 2,13% | 2050-08-06 | 500 M USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| UUS4636NAN3ASTRAZEN.FI. 24/34 | 4,38% | 5,00% | 2034-02-26 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| US46353AL2ASTRAZENECA PLC 15/25 | 4,25% | 3,38% | 2025-11-16 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| AAZN5549116AstraZeneca Finance LLC 4.875% 03-MAR-2033 | 4,22% | 4,88% | 2033-03-03 | 500 M USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| 50UCASTRAZENECA PLC 5.75% SNR EMTN 13/11/2031 | 4,15% | 5,75% | 2031-11-13 | 350 M GBP | 1.000,00 GBP | 50.000,00 GBP | AstraZeneca PLC |
| UUS4636NAM5ASTRAZEN.FI. 24/31 | 4,12% | 4,90% | 2031-02-26 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| AAZN5193314AstraZeneca Finance LLC 2.25% 28-MAY-2031 | 4,12% | 2,25% | 2031-05-28 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| UUS4636NAL7ASTRAZEN.FI. 24/29 | 4,08% | 4,85% | 2029-02-26 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| UUS4636NAK9ASTRAZEN.FI. 24/27 | 4,03% | 4,80% | 2027-02-26 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| US46353AV0ASTRAZENECA 20/26 | 4,00% | 0,70% | 2026-04-08 | 1,2 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| US46353AW8ASTRAZENECA 20/30 | 3,99% | 1,38% | 2030-08-06 | 1,3 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| AAZN5549115AstraZeneca Finance LLC 4.9% 03-MAR-2030 | 3,98% | 4,90% | 2030-03-03 | 650 M USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| US46353AT5ASTRAZENECA 18/29 | 3,96% | 4,00% | 2029-01-17 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| UUS4636NAA1ASTRAZEN.FI. 21/26 | 3,95% | 1,20% | 2026-05-28 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| US46353AN8ASTRAZENECA PLC 17/27 | 3,93% | 3,13% | 2027-06-12 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca PLC |
| AAZN5193317AstraZeneca Finance LLC 1.75% 28-MAY-2028 | 3,92% | 1,75% | 2028-05-28 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| AAZN5549114AstraZeneca Finance LLC 4.875% 03-MAR-2028 | 3,92% | 4,88% | 2028-03-03 | 1,1 B USD | 1.000,00 USD | 2.000,00 USD | AstraZeneca Finance LLC |
| XXS287290977ASTRAZEN.FI. 24/33 MTN | 3,18% | 3,28% | 2033-08-05 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AstraZeneca Finance LLC |
| XS259310547ASTRAZENECA 23/32 MTN | 3,10% | 3,75% | 2032-03-03 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AstraZeneca PLC |
| XXS287290969ASTRAZEN.FI. 24/30 MTN | 2,97% | 3,12% | 2030-08-05 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | AstraZeneca Finance LLC |
| XS259310539ASTRAZENECA 23/27 MTN | 2,87% | 3,63% | 2027-03-03 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AstraZeneca PLC |
| XS234766350ASTRAZENECA 21/29 MTN | 2,77% | 0,38% | 2029-06-03 | 800 M EUR | 1.000,00 EUR | 100.000,00 EUR | AstraZeneca PLC |
| XS141140442ASTRAZENECA 16/28 MTN | 2,56% | 1,25% | 2028-05-12 | 800 M EUR | 1.000,00 EUR | 100.000,00 EUR | AstraZeneca PLC |